Meeting an unmet pharma need by smoothing the way to a connected future
In the June issue of ONdrugDelivery magazine, SHL Medical’s Chelsea Williams, Nagisa Kobashi, and Nils Weber explore the exciting opportunities that a digital health ecosystem poses for more personalized, precise, and patient-centric care delivery.
By facilitating applications such as AI-based disease management, continuous adherence monitoring, and even predictive and preventive care, the digital health ecosystem would accelerate the shift from providers and institutions to patients and home settings. However, as the article explains, pharma and biotech companies have many unmet needs on the path to realizing these possibilities. Williams, Kobashi, and Weber argue that meeting these demands will require not just data connections between devices but deep partnerships between digital device innovators, biopharmaceutical companies, and healthcare providers.
The authors also highlight why SHL Medical, as an industry leader in autoinjector design and development, offers partners the skills, technology, and strategic vision necessary to pioneer new healthcare delivery solutions. They also discuss how SHL Medical is already laying the groundwork for the ecosystem, by provisioning demo kits to help pharma partners launch exploratory feasibility studies and connected device mock trials.
Read the article here to read more about SHL’s expanding digital health ecosystem. To request a demo kit or for other inquiries, reach out to SHL’s digital health representatives at digital@shl-medical.com.
